Claims
- 1. A compound of formula II ##STR227## wherein X.sub.1, X.sub.2 and X.sub.3 are the same or different and represent H, Cl, Br, F, CF.sub.3, NO.sub.2, NH.sub.2, OH, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, benzyloxy, acetamido, acetoxy, CHO, COOH or a group of the formula --O--C(CH.sub.3).sub.2 --COY.sup.1 wherein Y.sup.1 is OH or C.sub.1 -C.sub.4 alkoxy; R, X.sub.4 and X.sub.5 are the same or different and represent hydrogen or C.sub.1-4 alkyl;
- R' represents H, C.sub.1-4 alkyl, or acetyl; and
- Y represents a O--CH.sub.2 --CH.sub.2 --NZ.sub.1 Z.sub.2 group wherein Z.sub.1 and Z.sub.2 each are C.sub.1-4 alkyl or Z.sub.1 and Z.sub.2 together represent alkylene which with the nitrogen atom to which they are bond forms a 5 to 7 membered N-heterocyclus; or an acid addition salt thereof.
- 2. The compound as defined in claim 1 wherein R is CH.sub.3, X.sub.4 and X.sub.5 are hydrogen, R' is hydrogen, X.sub.1 is hydrogen or chlorine and X.sub.2 and X.sub.3 are hydrogen.
- 3. The compound of formula II as defined in claim 1 wherein X.sub.1, X.sub.2 and X.sub.3 are the same or different and represent H, Cl, Br, F, CF.sub.3, OH, C.sub.1-4 alkyl or C.sub.1 -C.sub.4 alkoxy.
- 4. A pharmaceutical composition for the trreatment of hyperlipaemia comprising a therapeutically active amount of a compound as claimed in claim 1 or a non-toxic acid-addition salt thereof, and a physiologically acceptable pharmaceutical excipient.
- 5. A compound of the formula: ##STR228## wherein X.sub.1 is hydrogen or chlorine, R is CH.sub.3, R' is hydrogen and Y represents a group of the formula ##STR229##
- 6. The compound as defined in claim 5 wherein Y is ##STR230##
- 7. The compound as defined in claim 5 wherein Y is ##STR231##
- 8. The compound as defined in claim 7, wherein X.sub.1 is hydrogen.
- 9. The compound as defined in claim 5 wherein Y is O--CH.sub.2 --CH.sub.2 --N(C.sub.2 H.sub.5).sub.2.
- 10. A pharmaceutical composition for the treatment of hyperlipaemia comprising a therapeutically active amount of a compound as claimed in claim 5 or a non-toxic acid addition salt thereof and a physiologically acceptable pharmaceutical excipient.
Priority Claims (2)
| Number |
Date |
Country |
Kind |
| 5979/75 |
Feb 1975 |
GBX |
|
| 50630/75 |
Dec 1975 |
GBX |
|
Parent Case Info
This is a division, of application Ser. No. 656,711, filed Feb. 9, 1977; now U.S. Pat. No. 4,072,705.
US Referenced Citations (7)
Foreign Referenced Citations (1)
| Number |
Date |
Country |
| 2356655 |
May 1974 |
DEX |
Divisions (1)
|
Number |
Date |
Country |
| Parent |
656711 |
Feb 1977 |
|